Twin Tree Management, LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Twin Tree Management, LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$59,210
+0.2%
1,550
-5.4%
0.00%
Q2 2023$59,119
-91.9%
1,639
-91.4%
0.00%
-100.0%
Q1 2023$731,911
-62.7%
19,165
-44.4%
0.00%
-75.0%
Q4 2022$1,962,424
+556.3%
34,489
+356.5%
0.00%
+300.0%
Q3 2022$299,000
+1561.1%
7,555
+1747.2%
0.00%
Q2 2022$18,000
-95.3%
409
-95.2%
0.00%
-100.0%
Q2 2021$384,000
+168.5%
8,446
+147.0%
0.00%0.0%
Q1 2021$143,000
+23.3%
3,420
+26.0%
0.00%
Q4 2020$116,0002,7150.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders